Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
DIRECTV ( DTV - Analyst Report ) reported mixed financial results for the second quarter of 2012. The company generated a record high net customer addition in Latin America, increased ARPU in the U.S., and higher operating margin and OPBDA.
Side by side, for the first time in its history, DIRECTV suffered a quarterly net customer loss in the U.S., in the previous quarter. Management cited stricter credit standards and reduced promotional discounts are the primary reasons for net subscriber loss in the U.S. DIRECTV lost a net 52,000 customers in the last quarter. The company’s closest rival DISH Network Corp. ( DISH - Analyst Report ) outpaced DIRECTV in terms of net subscriber loss (10,000) in the previous quarter.
DIRECTV is trying hard to establish itself as a premier pay-TV operator targeting higher-quality subscribers. Management is confident that it will be able to achieve its long-term financial goals in 2013 without any hiccup. However, competitive threats to the pay-TV industry and slow economic growth are near-term concerns. We believe the stock is fairly valued and, thus, maintain our long-term Neutral recommendation on the stock.
Increased demand for HD DVR services has induced the company to focus more on new product development. The Whole-Home DVR penetration has more than doubled year over year. The company is also planning to launch a new product called ‘Home Media Center’ in the upcoming quarters. The new device not only records five shows at one time but also has double storage capacity as compared to traditional HD DVR. The innovative Nomad device, which provides flexibility to customers to watch programs anywhere, is also gaining popularity.
Read the full Analyst Report on DTV
Read the full Analyst Report on DISH